文献速递关节外科

一体式双动髋臼组件在中高风险脱位患者初次全髋置换中至少5年随访安全有效

Monobloc Dual Mobility With a Minimum 5-Year Follow-Up: A Safe and Effective Solution in Primary Total Hip Arthroplasty.
PubMed 文献 · J Arthroplasty · 2021-09-16

该研究为单术者连续207例初次全髋关节置换术(THA)患者(脱位高风险)植入一体式双动(DM)髋臼组件,随访至少5年。结果显示无脱位、无因无菌性松动翻修,髋臼组件生存率99%,功能评分改善,提示一体式DM组件可可靠预防脱位且中期生存率良好。

要点

  • 一体式双动髋臼组件在高脱位风险患者初次THA中至少5年随访无脱位发生。
  • 髋臼组件因翻修生存率99%,无因无菌性松动翻修,影像学无髋臼透亮线。
  • 205例中7例(3.4%)翻修,5例因假体周围骨折(股骨侧),2例因感染。

核心结论

  • 一体式双动组件可可靠预防高脱位风险患者初次THA术后脱位,中期随访假体生存率优异、影像学固定良好且功能改善。

研究设计与样本

  • 单术者连续系列研究,纳入207例因脱位高风险接受初次THA并植入一体式双动髋臼组件的患者,回顾性收集资料,所有患者随访至少5年。

主要发现

  • 影像学分析未发现任何患者存在髋臼透亮线,无因无菌性松动翻修,无脱位发生。
  • 205例患者中7例(3.4%)接受翻修,其中5例因假体周围骨折(股骨侧),2例因感染。
  • 髋臼组件因翻修的生存率为99%。
  • 平均VR-12生理评分从术前7(SD 13.7)改善至末次随访9.5(SD 17.6)。
  • 髋关节功能障碍与骨关节炎评分(HOOS)从术前8(SD 17.9)改善至末次随访21.2(SD 37)。

关键数值与推荐

  • 髋臼组件因翻修生存率为99%。
  • 205例中7例(3.4%)翻修,5例因假体周围骨折(股骨侧),2例因感染。
  • 平均VR-12生理评分术前7(SD 13.7)至末次随访9.5(SD 17.6)。
  • HOOS评分术前8(SD 17.9)至末次随访21.2(SD 37)。

临床怎么用

  • 对于脱位高风险的初次THA患者,可考虑使用一体式双动髋臼组件以预防脱位。
  • 中期随访中该组件假体生存率及影像学固定良好,功能评分改善,可作为高脱位风险患者的可靠选择。

局限性

  • 单术者回顾性连续系列研究,样本量有限,随访时间为中期(至少5年),未设置对照组。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Instability constitutes over 20% of revisions after total hip arthroplasty (THA). Dual mobility (DM) designs were introduced as a solution to this problem. However, the few publications that have reported promising results for monobloc DM constructs have been limited by sample size or length of follow-up. The purpose of this study is to evaluate mid-term outcomes (minimum 5-year follow-up) of a single-surgeon series utilizing a monobloc DM acetabular component in patients with high risk for dislocation. METHODS: This is a single-surgeon consecutive series of 207 primary THAs implanted with a monobloc DM component in patients who were considered at high risk for dislocation. Patient demographics and case-specific data were collected retrospectively. All patients had a minimum of 5-year follow-up. The Mann-Whitney U test was used to assess continuous variables, whereas categorical variables were analyzed using the chi-square test. Survival probability was calculated using the Kaplan-Meier method. RESULTS: Radiographic analysis did not reveal acetabular radiolucency in any patients, and there were no revisions for aseptic loosening. In addition, there were no dislocations. Seven of 205 patients (3.4%) were revised, 5 on the femoral side due to periprosthetic fracture and the remaining two for infection. Survivorship of the acetabular component from revision was 99%. The mean Veteran RAND (VR-12) physical score improved from 7 (standard deviation [SD]: 13.7) preoperatively to 9.5 (SD: 17.6) at the final follow-up. Similarly, the hip disability osteoarthritis score improved from 8 (SD: 17.9) preoperatively to 21.2 (SD: 37). CONCLUSION: Monobloc DM components reliably prevent dislocation after primary THA in high-risk patients. At mid-term follow-up, this DM monobloc component demonstrates excellent implant survivorship, radiographic fixation, and improved functional outcomes.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Gkiatas I, Tarity TD, Nocon AA, et al. Monobloc Dual Mobility With a Minimum 5-Year Follow-Up: A Safe and Effective Solution in Primary Total Hip Arthroplasty. J Arthroplasty. 2021. PMID: 34593287. doi:10.1016/j.arth.2021.09.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。